This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Apr 2023

To date, LAR appears to be a debated and complex entity.1 According to Melone and colleagues, the story of LAR can be traced back to 1975, when Huggins et al. studied a group of patients with typical symptoms of AR to house dust mites but with negative skin-prick tests and serum immunoglobin E (IgE).1 Click on the link below to read a comprehensive review by Melone and colleagues summarizing the pathophysiological, diagnostic and therapeutic aspects of LAR.1
 

Read more

References:

  1. Melone G et al. Int Arch Allergy Immunol 2023;184:12–20.

To report an Adverse Event, please contact the toll free line 0800 CALL GSK (0800 2255 475) or send an email